Trial intelligence / Profile preview

Effect of Inhaled Nitric Oxide on Exercise in Hypoxia

NCT04231773Phase 2Completed

Sponsor
University of Alberta
Start
Aug 2020
Primary completion
Dec 2021
Modality
DNA Intercalators/Alkylators, Inhalation Devices
Countries
1
01

Overview

A Phase 2 trial of nitric oxide in hypoxia, sponsored by University of Alberta. Started Aug 2020; status: completed.

02

Drugs

nitric oxide
03

Conditions

hypoxia

Beyond the preview

Go deeper on NCT04231773.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04231773.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call